This document was published more than 2 years ago. The nature of the evidence may have changed.
Benign prostate hyperplasia (BPH) is a condition associated with ageing that affects nearly all men. Some of these men have urinary problems, and annually in Sweden around 4 500 receive surgery for an enlarged prostate. Many with mild or moderate bother are treated with medication, or require no treatment at all. If left untreated, obstructed urinary outflow can cause serious retention of urine, which damages the kidneys. Urinary retention can be life threatening.
Approximately 10 diagnostic methods are available to identify the group of men in whom an enlarged prostate causes urinary problems. Several different surgical treatment options are available; some are well established and others are experimental. Also, several drugs were introduced during the 1990s. Hence, SBU determined that a systematic review of the scientific literature addressing these different methods is necessary. The most important conclusions from this project are presented below.
How to cite this report: SBU. Benign prostatic obstruction. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2011. SBU report no 209 (in Swedish).
presents a comprehensive, systematic assessment of available scientific evidence. The certainty of the evidence for each finding is systematically reviewed and graded. Full assessments include economic, social, and ethical impact analyses.
SBU assessments are performed by a team of leading professional practitioners and academics, patient/user representatives and SBU staff. Prior to approval and publication, assessments are reviewed by independent experts, SBU’s Scientific Advisory Committees and Board of Directors.